“Neoadjuvant chemotherapy in muscle-invasive bladder cancer (MIBC):current status, indications and toxicity rates”

Evidence based review of current use of neoadjuvant chemotherapy for muscle invasive bladder cancer. Toxicity and oncological outcomes rates according to randomized data and real-life use and publications

La partecipazione è gratuita e aperta a tutti.